Abstract:In this study a new chitosan (CS) derivative, galactosylated chitosan (GC), was synthesized and used to prepare norcantharidin-associated GC nanoparticles (NCTD-GC NPs) by taking advantage of the ionic cross-linkage between the molecules of the anti-hepatocarcinoma medicine NCTD and of the GC as carrier. NCTD-GC NPs were obtained with average particle size of 118.68 +/- 3.37 nm, entrapment efficiency of 57.92 +/- 0.40%, and drug-loading amount of 10.38 +/- 0.06%. Several important factors influencing the entrapment efficiency, drug-loading amount, and particle size of NCTD-GC NPs were studied. The characteristics of sustained and pH-sensitive release of NCTD from NCTD-GC NPs in vitro were studied. In addition, in vitro cellular uptake and cytotoxicity of nanoparticles to hepatoma cell lines SMMC-7721 and HepG2 were also investigated. In vitro, and compared to CS-based NCTD-CS NPs, NCTD-GC NPs demonstrated satisfactory compatibility with hepatoma cells and strong cytotoxicity against hepatocellular carcinoma cells. In vivo antitumor activity of NCTD-GC NPs was evaluated in mice bearing H22 liver tumors. NCTD-GC NPs displayed tumor inhibition effect in mice, better than either the free NCTD or the NCTD-CS NPs. As a hepatocyte-targeting carrier, GC NPs are potentially promising for clinical applications.From the Clinical Editor: In this paper, a galactosylated chitosan (GC), was synthesized and norcantharidin (NCTD)-associated galactosylated chitosan nanoparticles (NCTDGC NPs) were generated by coupling NCTD - an anti-hepatocarcinoma drug - and GC as carrier. Compared to chitosan nanoparticles, NCTD-GC-NPs demonstrated satisfactory compatibility with hepatoma cells and strong cytotoxicity against the cells. (C) 2010 Elsevier Inc. All rights reserved.

Synthesis of Hepatocyte-Targeting Norcantharidin Prodrug and Preparation of Its Nanoparticles

Preparation of a Novel Liver-Targeting Nanoparticle of Norcantharidin Derivative and Evaluation of Its Anti-Tumour Activity

N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy.

Preparation of Norcantharidin N-galaetosylated Chitosan Nanoparticles and Its Characteristics

Novel Norcantharidin-Loaded Liver Targeting Chitosan Nanoparticles to Enhance Intestinal Absorption

Norcantharidin-Associated Galactosylated Chitosan Nanoparticles For Hepatocyte-Targeted Delivery

Study on an Active Hepatocyte-Targeting Antineoplastic Activity of Norcantharidin-Loaded Galactosylated Chitosan Nanoparticles

Investigation on Anticancer Activity of Nanoparticles Loaded Lactosyl-Norcantharidin

Studies on Pharmacokinetics of Lactosyl-norcantharidin Nanoparticals in Rats

Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate.

Hepatocyte-Targeted Delivery Using Ph-Sensitive Liposomes Loaded with Lactosylnorcantharidin Phospholipid Complex: Preparation, Characterization, and Therapeutic Evaluation in Vivo and in Vitro

Study on the Distribution and Liver Targeting of Norcantharidin Nanoparticles in Mice

Preparation and in Vitro Antineoplastic Activity of Norcantharidi N-Associated Galactosylated Chitosan Nanoparticles

Preparation of lactosyl-norcantharitin phospholipid complex and its pH-sensitive liposomes

Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma.

Preparation and Evaluation of N-Caproyl Chitosan Nanoparticles Surface Modified with Glycyrrhizin for Hepatocyte Targeting

Studies on Preparation and Drug Release Characteristics of Norcantharidin Liposomes in Vitro

Preparation, Characterization and Drug Release in Vitro of Galactosylated Chitosan-Graft-PEG Nanoparticles

Synthesis, in Vitro and in Vivo Evaluation of New Norcantharidin-Conjugated Hydroxypropyltrimethyl Ammonium Chloride Chitosan Derivatives As Polymer Therapeutics

Synthesis and in vitro cellular evaluation of novel anti-tumor norcantharidin-conjugated chitosan derivatives

Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity